Pulmonary arterial hypertension in systemic lupus erythematosus: Current status and future direction

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Dhala, Atiya ^a,b  

^a North Central Bronx Hospital   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; ENDOTHELIAL CELL ANTIBODY; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; GLUCOCORTICOID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ILOPROST; NUCLEAR FACTOR; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN; SILDENAFIL; THROMBOXANE A2; UNIPROST; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT; VASODILATOR AGENT;

ANTIPHOSPHOLIPID SYNDROME; ASCITES; AUTOIMMUNITY; BLALOCK HANLON OPERATION; CD4+ CD25+ T LYMPHOCYTE; CENTRAL VENOUS PRESSURE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIGITAL GANGRENE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE REGISTRY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ENDOCARDITIS; ENZYME ACTIVATION; FATIGUE; FIBROSING ALVEOLITIS; GANGRENE; HEART CATHETERIZATION; HEART MURMUR; HEART TRANSPLANTATION; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; LEG EDEMA; LIBMAN SACKS ENDOCARDITIS; LUNG HEMODYNAMICS; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MORTALITY; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PLEURA EFFUSION; POLYSOMNOGRAPHY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE; QUALITY OF LIFE; RAYNAUD PHENOMENON; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOSIS; TREATMENT INDICATION; VASCULITIS; BLOOD; FEMALE; IMMUNOLOGY; PREGNANCY;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTICARDIOLIPIN; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PROGNOSIS; RAYNAUD DISEASE; SURVIVAL RATE; VASODILATOR AGENTS;

EID: 84859772546     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/854941     Document Type: Review

References (94)

1. McLaughlin V. V., Archer S. L., Badesch D. B., Barst R. J., Farber H. W., Lindner J. R., Mathier M. A., McGoon M. D., Park M. H., Rosenson R. S., Rubin L. J., Tapson V. F., ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Journal of the American College of Cardiology 2009 53 17 1573 1619. Circulation, vol. 119, no. 16, pp. 22502294
2. Hassoun P. M., Pulmonary arterial hypertension complicating connective tissue diseases Seminars in Respiratory and Critical Care Medicine 2009 30 4 429 439
3. Yokoi T., Tomita Y., Fukaya M., Ichihara S., Kakudo K., Takahashi Y., Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions Archives of Pathology and Laboratory Medicine 1998 122 5 467 470 (Pubitemid 28237542)
4. Duong H. T., Erzurum S. C., Asosingh K., Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation Angiogenesis 2011 14 4 411 422
5. Condliffe R., Kiely D. G., Peacock A. J., Corris P. A., Gibbs J. S.R., Vrapi F., Das C., Elliot C. A., Johnson M., DeSoyza J., Torpy C., Goldsmith K., Hodgkins D., Hughes R. J., Pepke-Zaba J., Coghlan J. G., Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era American Journal of Respiratory and Critical Care Medicine 2009 179 2 151 157
6. Chung L., Liu J., Parsons L., Hassoun P. M., McGoon M., Badesch D. B., Miller D. P., Nicolls M. R., Zamanian R. T., Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype Chest 2010 138 6 1383 1394
7. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., Yaici A., Weitzenblum E., Cordier J. F., Chabot F., Dromer C., Pison C., Reynaud-Gaubert M., Haloun A., Laurent M., Hachulla E., Simonneau G., Pulmonary arterial hypertension in France: results from a national registry American Journal of Respiratory and Critical Care Medicine 2006 173 9 1023 1030
8. Peacock A. J., Murphy N. F., McMurrey J. J.V., Caballero L., Stewart S., An epidemiological study of pulmonary arterial hypertension European Respiratory Journal 2007 30 1 104 109 (Pubitemid 47074013)
9. Prabu A., Patel K., Yee C. S., Nightingale P., Situnayake R. D., Thickett D. R., Townend J. N., Goron C., Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus Rheumatology 2009 48 12 1506 1511
10. Simonson J. S., Schiller N. B., Petri M., Hellmann D. B., Pulmonary hypertension in systemic lupus erythematosus Journal of Rheumatology 1989 16 7 918 925 (Pubitemid 19220204)
11. Winslow T. M., Ossipov M. A., Fazio G. P., Simonson J. S., Redberg R. F., Schiller N. B., Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus American Heart Journal 1995 129 3 510 515
12. Quismorio F. P. Jr., Sharma O., Koss M., Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus Seminars in Arthritis and Rheumatism 1984 13 4 349 359 (Pubitemid 14079399)
13. Haas C., Pulmonary hypertension associated with systemic lupus erythematosus Bulletin de l'Académie Nationale de Médecine 2004 188 6 985 997 (Pubitemid 40081463)
14. Arnaud L., Agard C., Haroche J., Cacoub P., Piette J. C., Amoura Z., Pulmonary arterial hypertension in systemic lupus erythematosus Revue de Medecine Interne 2011 32 11 689 697
15. Asherson R. A., Higenbottam T. W., Dinh Xuan A. T., Khamashta M. A., Hughes G. R. V., Pulmonary hypertension in a lupus clinic: experience with twenty-four patients Journal of Rheumatology 1990 17 10 1292 1298 (Pubitemid 20382853)
16. Asherson R. A., Mackworth-Young C. G., Boey M. L., Pulmonary hypertension in systemic lupus erythematosus British Medical Journal 1983 287 6398 1024 1025 (Pubitemid 13009251)
17. Kasparian A., Floros A., Gialafos E., Kanakis M., Tassiopoulos S., Kafasi N., Vaiopoulos G., Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus Lupus 2007 16 7 505 508 (Pubitemid 47242524)
18. Pan T. L. T., Thumboo J., Boey M. L., Primary and secondary pulmonary hypertension in systemic lupus erythematosus Lupus 2000 9 5 338 342 (Pubitemid 30389035)
19. Miyamichi-Yamamoto S., Fukumoto Y., Sugimura K., Ishii T., Satoh K., Miura Y., Tatebe S., Nochioka K., Aoki T., Doe Z., Shimokawa H., Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease Circulation Journal 2011 75 11 2668 2674
20. Jais X., Launay D., Yaici A., Le Pavec J., Tchérakian C., Sitbon O., Simonneau G., Humbert M., Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases Arthritis and Rheumatism 2008 58 2 521 531 (Pubitemid 351294886)
21. Sanchez O., Sitbon O., Jas X., Simonneau G., Humbert M., Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension Chest 2006 130 1 182 189 (Pubitemid 44116858)
22. Badesch D. B., Hill N. S., Burgess G., Sildenafil for pulmonary arterial hypertension associated with connective tissue disease The Journal of Rheumatology 2007 34 12 2417 2422 (Pubitemid 350230665)
23. Gali N., Ghofrani H. A., Torbicki A., Barst R. J., Rubin L. J., Badesch D., Fleming T., Parpia T., Burgess G., Branzi A., Grimminger F., Kurzyna M., Simonneau G., Sildenafil citrate therapy for pulmonary arterial hypertension The New England Journal of Medicine 2005 353 20 2148 2157 (Pubitemid 41653106)
24. Rubin L. J., Badesch D. B., Barst R. J., Gali N., Black C. M., Keogh A., Pulido T., Frost A., Roux S., Leconte I., Landzberg M., Simonneau G., Bosentan therapy for pulmonary arterial hypertension The New England Journal of Medicine 2002 346 12 896 903 (Pubitemid 34984638)
25. Oudiz R. J., Schilz R. J., Barst R. J., Galié N., Rich S., Rubin L. J., Simonneau G., Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease Chest 2004 126 2 420 427 (Pubitemid 39093426)
26. Olschewski H., Simonneau G., Gali N., Higenbottam T., Naeije R., Rubin L. J., Nikkho S., Speich R., Hoeper M. M., Behr J., Winkler J., Sitbon O., Popov W., Ardeschir Ghofrani H., Manes A., Kiely D. G., Ewert R., Meyer A., Corris P. A., Delcroix M., Gomez-Sanchez M., Siedentop H., Seeger W., Inhaled iloprost for severe pulmonary hypertension The New England Journal of Medicine 2002 347 5 322 329 (Pubitemid 34815354)
27. Robbins I. M., Gaine S. P., Schilz R., Tapson V. F., Rubin L. J., Loyd J. E., Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus Chest 2000 117 1 14 18 (Pubitemid 30053613)
28. Orens J. B., Martinez F. J., Lynch J. P. III, Pleuropulmonary manifestations of systemic lupus erythematosus Rheumatic Disease Clinics of North America 1994 20 1 159 193 (Pubitemid 24066016)
29. Fernandez-Alonso J., Zulueta T., Reyes-Ramirez J. R., Castillo-Palma M. J., Sanchez-Roman J., Pulmonary capillary hemangiomatosis as cause of pulmonary hypertension in a young woman with systemic lupus erythematosus Journal of Rheumatology 1999 26 1 231 233 (Pubitemid 29051428)
30. Woolf D., Voigt M. D., Jaskiewicz K., Kalla A. A., Pulmonary hypertension associated with non-cirrhotic portal hypertension in systemic lupus erythematosus Postgraduate Medical Journal 1994 70 819 41 43 (Pubitemid 24050570)
31. De Clerck L. S., Michielsen P. P., Ramael M. R., Janssens E., Van Maercke Y. M., Van Marck E. A., Stevens W. J., Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies Journal of Rheumatology 1991 18 12 1919 1921
32. Hubscher O., Eimon A., Elsner B., Arana R. M., Fatal post-partum pulmonary vasculitis in systemic lupus erythematosus Clinical Rheumatology 1984 3 4 547 550
33. Haupt H. M., Moore G. W., Hutchins G. M., The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients American Journal of Medicine 1981 71 5 791 798 (Pubitemid 12192356)
34. Rubin L. A., Geran A., Rose T. H., Cohen H., A fatal pulmonary complication of lupus in pregnancy Arthritis and Rheumatism 1995 38 5 710 714
35. Corrin B., Spencer H., Turner Warwick M., Beales S. J., Hamblin J. J., Pulmonary veno occlusion. An immune complex disease? Virchows Archiv A 1974 364 1 81 91
36. Sasaki N., Kamataki A., Sawai T., A histopathological study of pulmonary hypertension in connective tissue disease Allergology International 2011 60 4 411 417
37. Shen J. Y., Chen S. L., Wu Y. X., Pulmonary hypertension in systemic lupus erythematosus Rheumatology International 1999 18 4 147 151
38. Yoshio T., Masuyama J. I., Kohda N., Hirata D., Sato H., Iwamoto M., Mimori A., Takeda A., Minota S., Kano S., Association of interleukin 6 release from endothelial cells and pulmonary hypertension in SLE Journal of Rheumatology 1997 24 3 489 495 (Pubitemid 27153413)
39. Kamen D. L., Strange C., Pulmonary Manifestations of Systemic Lupus Erythematosus Clinics in Chest Medicine 2010 31 3 479 488
40. Nicolls M. R., Tamosiuniene R., Voelkel N. F., Nicolls M. R., Inflammation in pulmonary hypertension: how immunobiology provides the missing link between these conditions. Advances in pulmonary hypertension Autumn 2006 5 3 26 29
41. Harel L., Straussberg R., Rudich H., Cohen A. H., Amir J., Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes Clinical Infectious Diseases 2000 30 3 500 503 (Pubitemid 30205295)
42. Abu-Shakra M., Sukenik S., Buskila D., Systemic sclerosis: another rheumatic disease associated with hepatitis C virus infection Clinical Rheumatology 2000 19 5 378 380
43. Morse J., Barst R., Horn E., Cuervo N., Deng Z., Knowles J., Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations Journal of Rheumatology 2002 29 11 2379 2381 (Pubitemid 35266029)
44. Corrin B., Nicholson A. G., Pathology of the Lungs 2011 3rd
45. Loyd J. E., Pulmonary arterial hypertension: insights from genetic studies Proceedings of the American Thoracic Society 2011 8 2 154 157
46. Roncoroni A. J., Alvarez C., Molinas F., Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus Respiration 1992 59 1 52 56
47. Rustin M. H. A., Bull H. A., Machin S. J., Isenberg D. A., Snaith M. L., Dowd P. M., Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity Journal of Investigative Dermatology 1988 90 5 744 748
48. Cefle A., Inanc M., Sayarlioglu M., Kamali S., Gul A., Ocal L., Aral O., Konice M., Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome Rheumatology International 2011 31 2 183 189
49. Nicolls M. R., Taraseviciene-Stewart L., Rai P. R., Badesch D. B., Voelkel N. F., Autoimmunity and pulmonary hypertension: a perspective European Respiratory Journal 2005 26 6 1110 1118 (Pubitemid 41829945)
50. Mihai C., Tervaert J. W. C., Anti-endothelial cell antibodies in systemic sclerosis Annals of the Rheumatic Diseases 2010 69 2 319 324
51. Domiciano D. S., Carvalho J. F., Shoenfeld Y., Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases Lupus 2009 18 13 1233 1238
52. Pullamsetti S. S., Savai R., Janssen W., Dahal B. K., Seeger W., Grimminger F., Ghofrani H. A., Weissmann N., Schermuly R. T., Inflammation, immunological reaction and role of infection in pulmonary hypertension Clinical Microbiology and Infection 2011 17 1 7 14
53. Jamieson S. W., Kapelanski D. P., Sakakibara N., Manecke G. R., Thistlethwaite P. A., Kerr K. M., Channick R. N., Fedullo P. F., Auger W. R., Mcgregor C. G., Atkinson A. W., Bavaria J. E., D'Armini A. M., Pulmonary endarterectomy: experience and lessons learned in 1,500 cases Annals of Thoracic Surgery 2003 76 5 1457 1464 (Pubitemid 37378293)
54. Dartevelle P., Fadel E., Mussot S., Chapelier A., Hervé P., de Perrot M., Cerrina J., Ladurie F. L., Lehouerou D., Humbert M., Sitbon O., Simonneau G., Chronic thromboembolic pulmonary hypertension European Respiratory Journal 2004 23 4 637 648 (Pubitemid 38456010)
55. Maggiorini M., Knoblauch A., Schneider J., Russi E. W., Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome European Respiratory Journal 1997 10 3 727 730 (Pubitemid 27112597)
56. Nguyen V. A., Gotwald T., Prior C., Obermoser G., Sepp N., Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus? Lupus 2005 14 7 557 560 (Pubitemid 41161089)
57. Asherson R. A., Hackett D., Gharavi A. E., Pulmonary hypertension in systemic lupus erythematosus: a report of three cases Journal of Rheumatology 1986 13 2 416 420 (Pubitemid 16034602)
58. Mackworth-Young C. G., Gharavi A. E., Boey M. L., Hughes G. R. V., Portal and pulmonary hypertension in a case of systematic lupus erythematosus: possible relationship with a clotting abnormality European Journal of Rheumatology and Inflammation 1984 7 3 71 74 (Pubitemid 16002268)
59. Miyata M., Suzuki K., Sakuma F., Watanabe H., Kaise S., Nishimaki T., Kasukawa R., Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus International Archives of Allergy and Immunology 1993 100 4 351 354 (Pubitemid 23152107)
60. Merkel P. A., Chang Y., Pierangeli S. S., Convery K., Harris E. N., Polisson R. P., The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases American Journal of Medicine 1996 101 6 576 583 (Pubitemid 27150034)
61. Assous N., Allanore Y., Batteux F., Meune C., Toulon P., Weill B., Kahan A., Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury Clinical and Experimental Rheumatology 2005 23 2 199 204 (Pubitemid 40663000)
62. Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M. A., Antiphospholipid syndrome The Lancet 2010 376 9751 1498 1509
63. Crispin J. C., Martnez A., Alcocer-Varela J., Quantification of regulatory T cells in patients with systemic lupus erythematosus Journal of Autoimmunity 2003 21 3 273 276 (Pubitemid 37410115)
64. Liu M. F., Wang C. R., Fung L. L., Wu C. R., Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus Scandinavian Journal of Immunology 2004 59 2 198 202
65. Lian F., Chen D., Wang Y., Ye Y., Wang X., Zhan Z., Xu H., Liang L., Yang X., Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus. Rheumatology International. In press
66. Luo Y. F., Robbins I. M., Karatas M., Brixey A. G., Rice T. W., Light R. W., Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases Chest 2011 140 1 42 47
67. Arcasoy S. M., Christie J. D., Ferrari V. A., Sutton M. S.J., Zisman D. A., Blumenthal N. P., Pochettino A., Kotloff R. M., Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease American Journal of Respiratory and Critical Care Medicine 2003 167 5 735 740 (Pubitemid 36801751)
68. Farber H. W., Foreman A. J., Miller D. P., Mcgoon M. D., REVEAL Registry: correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension Congestive Heart Failure 2011 17 2 56 64
69. Rich J. D., Shah S. J., Swamy R. S., Kamp A., Rich S., Inaccuracy of doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice Chest 2011 139 5 988 993
70. Hodson P., Klemp P., Meyers O. L., Pulmonary hypertension in systemic lupus erythematosus: a report of four cases Clinical and Experimental Rheumatology 1983 1 3 241 245 (Pubitemid 14210284)
71. Hoeper M. M., Mayer E., Simonneau G., Rubin L. J., Chronic thromboembolic pulmonary hypertension Circulation 2006 113 16 2011 2020
72. Lang I. M., Chronic thromboembolic pulmonary hypertensionnot so rare after all The New England Journal of Medicine 2004 350 22 2236 2238 (Pubitemid 38669205)
73. Wolf M., Boyer-Neumann C., Parent F., Eschwege V., Jaillet H., Meyer D., Simonneau G., Thrombotic risk factors in pulmonary hypertension European Respiratory Journal 2000 15 2 395 399 (Pubitemid 30085971)
74. Lang I. M., Klepetko W., Pabinger I., No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH) Thrombosis and haemostasis 1996 76 3 476 477
75. Kasthuri R. S., Roubey R. A. S., Warfarin and the antiphospholipid syndrome: does one size fit all? Arthritis Care and Research 2007 57 8 1346 1347 (Pubitemid 350308828)
76. Klepetko W., Mayer E., Sandoval J., Trulock E. P., Vachiery J. L., Dartevelle P., Pepke-Zaba J., Jamieson S. W., Lang I., Corris P., Interventional and surgical modalities of treatment for pulmonary arterial hypertension Journal of the American College of Cardiology 2004 43 12, supplement 73S 80S (Pubitemid 38759721)
77. Espnola-Zavaleta N., Vargas-Barrn J., Colmenares-Galvis T., Cruz-Cruz F., Romero-Crdenas A., Keirns C., Amigo M. C., Echocardiographic evaluation of patients with primary antiphospholipid syndrome American Heart Journal 1999 137 5 973 978 (Pubitemid 29226310)
78. Turiel M., Sarzi-Puttini P., Peretti R., Bonizzato S., Muzzupappa S., Atzeni F., Rossi E., Doria A., Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome American Journal of Cardiology 2005 96 4 574 579 (Pubitemid 41132777)
79. Zavaleta N. E., Montes R. M., Soto M. E., Vanzzini N. A., Amigo M. C., Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study Journal of Rheumatology 2004 31 12 2402 2407 (Pubitemid 39603088)
80. Nesher G., Ilany J., Rosenmann D., Abraham A. S., Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment Seminars in Arthritis and Rheumatism 1997 27 1 27 35 (Pubitemid 27374246)
81. Shahian D. M., Labib S. B., Schneebaum A. B., Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus Journal of Cardiac Surgery 1995 10 2 133 139
82. Kato M., Kataoka H., Odani T., Fujieda Y., Otomo K., Oku K., Horita T., Yasuda S., Atsumi T., Ohira H., Tsujino I., Nishimura M., Koike T., The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review Lupus 2011 20 10 1047 1056
83. Benza R. L., Gomberg-Maitland M., Naeije R., Arneson C. P., Lang I. M., Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials Journal of Heart and Lung Transplantation 2011 30 9 982 989
84. Hennigan S., Channick R. N., Silverman G. J., Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report Lupus 2008 17 8 754 756
85. Levy R. D., Guerraty A. J., Yacoub M. H., Loertscher R., Prolonged survival after heart-lung transplantation in systemic lupus erythematosus Chest 1993 104 6 1903 1905 (Pubitemid 23360132)
86. Schwarz E. B., Manzi S., Risk of unintended pregnancy among women with systemic lupus erythematosus Arthritis Care and Research 2008 59 6 863 866 (Pubitemid 351847570)
87. Greenstone M. A., Delayed diagnosis of systemic lupus erythematosus associated pulmonary hypertension British Journal of Rheumatology 1991 30 5 391
88. Ray J., Sermer M., Systemic lupus erythematosus and pulmonary hypertension during pregnancy: report of a case fatality Canadian Journal of Cardiology 1996 12 8 753 756 (Pubitemid 26315722)
89. Martin W. L., Gordon C., Kilby M. D., Systemic lupus erythematosus The Lancet 2001 358 9281 586
90. Weiss B. M., Zemp L., Seifert B., Hess O. M., Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996 Journal of the American College of Cardiology 1998 31 7 1650 1657 (Pubitemid 28273311)
91. Quadrelli S. A., Alvarez C., Arce S. C., Paz L., Sarano J., Sobrino E. M., Manni J., Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies Lupus 2009 18 12 1053 1060
92. Kim W. U., Min J. K., Lee S. H., Park S. H., Cho C. S., Kim H. Y., Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study Clinical and Experimental Rheumatology 1999 17 5 539 545
93. Chung S. M., Lee C. K., Lee E. Y., Yoo B., Lee S. D., Moon H. B., Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension Clinical Rheumatology 2006 25 6 866 872 (Pubitemid 44473155)
94. Condliffe R., Kiely D. G., Peacock A. J., Initial results of the UK audit of pulmonary arterial hypertension associated with connective tissue disease European Heart Journal 2007 28 139 140